Guillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib

Basit Öğe Kaydı
dc.contributor.authorGeçgel, Aslı
dc.contributor.authorÖn, Sercan
dc.contributor.authorÇiftçi, Yeliz
dc.contributor.authorÖzkan, Oğuzcan
dc.contributor.authorAçar, Fatma Pınar
dc.contributor.authorKaraca, Burçak
dc.date.accessioned2025-03-20T09:45:09Z
dc.date.available2025-03-20T09:45:09Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.4274/balkanmedj.galenos.2024.2024-1-86
dc.identifier.endpage313
dc.identifier.issn2146-3123
dc.identifier.issue4
dc.identifier.pmid38572561
dc.identifier.scopus2-s2.0-85197986358
dc.identifier.scopusqualityQ1
dc.identifier.startpage312
dc.identifier.trdizinid1273602
dc.identifier.urihttps://doi.org/10.4274/balkanmedj.galenos.2024.2024-1-86
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1273602
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2148
dc.identifier.volume41
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherGalenos Publishing House
dc.relation.ispartofBalkan Medical Journal
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20250319
dc.subjectAntineoplastic Agents
dc.subjectFemale
dc.subjectGuillain-Barre Syndrome
dc.subjectHumans
dc.subjectImidazoles
dc.subjectMale
dc.subjectMelanoma
dc.subjectMiddle Aged
dc.subjectOximes
dc.subjectPyridones
dc.subjectPyrimidinones
dc.subjectB Raf kinase
dc.subjectdabrafenib
dc.subjectfluorodeoxyglucose f 18
dc.subjectglutamic acid
dc.subjecttrametinib
dc.subjectvaline
dc.subjectantineoplastic agent
dc.subjectdabrafenib
dc.subjectdipyrone
dc.subjectimidazole derivative
dc.subjectoxime
dc.subjectpyrimidinone derivative
dc.subjecttrametinib
dc.subjectadult
dc.subjectaxillary lymph node dissection
dc.subjectaxillary lymph node metastasis
dc.subjectBRAF gene
dc.subjectcancer adjuvant therapy
dc.subjectcancer surgery
dc.subjectcase report
dc.subjectclinical article
dc.subjectcongenital nevus
dc.subjectdrug withdrawal
dc.subjectdysphagia
dc.subjectechography
dc.subjectelectromyography
dc.subjectexcisional biopsy
dc.subjectfacial droop
dc.subjectfacial nerve paralysis
dc.subjectfollow up
dc.subjectgene mutation
dc.subjectGuillain Barre syndrome
dc.subjecthistopathology
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectLetter
dc.subjectlimb weakness
dc.subjectlumbar puncture
dc.subjectmale
dc.subjectmelanoma
dc.subjectmiddle aged
dc.subjectphysical examination
dc.subjectplasmapheresis
dc.subjectpositron emission tomography-computed tomography
dc.subjectreoperation
dc.subjectsentinel lymph node biopsy
dc.subjecttumor volume
dc.subjectdrug therapy
dc.subjectfemale
dc.subjectGuillain Barre syndrome
dc.subjectmelanoma
dc.titleGuillain-Barre Syndrome due to Adjuvant Therapy with Dabrafenib Plus Trametinib
dc.typeLetter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu